The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 10, 2017

Filed:

Apr. 29, 2011
Applicants:

Matthew Levy, New Rochelle, NY (US);

Amy Yan, New Rochelle, NY (US);

Brian Wengerter, Bronx, NY (US);

Inventors:

Matthew Levy, New Rochelle, NY (US);

Amy Yan, New Rochelle, NY (US);

Brian Wengerter, Bronx, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/04 (2006.01); C12N 15/11 (2006.01); C12N 15/115 (2010.01); C12N 15/87 (2006.01); C07H 21/02 (2006.01); C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
C07H 21/04 (2013.01); C12N 15/111 (2013.01); C12N 15/115 (2013.01); C12N 15/87 (2013.01); A61K 48/00 (2013.01); C12N 2310/11 (2013.01); C12N 2310/16 (2013.01); C12N 2310/334 (2013.01); C12N 2310/335 (2013.01); C12N 2310/3519 (2013.01); C12N 2320/13 (2013.01); C12N 2320/32 (2013.01);
Abstract

The present invention provides methods of preparing an oligonucleotide, nucleoside or nucleoside analog for selective introduction into a subject's cells, the method comprising (1) selecting a targeted aptamer, internalizing nucleic acid or tumor-homing nucleic acid via iterative rounds of selection, and (i) hybridizing it to an oligonucleotide, (ii) replacing one or more nucleotide with a nucleoside or nucleoside analog, or (iii) synthesizing the it with one or more nucleoside or nucleoside analogs; or (2) preparing a naive combinatorial aptamer, internalizing nucleic acid or tumor-homing nucleic acid prodrug library, and running iterative rounds of selection for the cells. The present invention also provides the agent, the pharmaceutical composition, and methods of treating or preventing cancer and/or viral infection, the method comprising administration of the oligonucleotide, nucleoside or nucleoside analog for selective introduction into a subject's cells.


Find Patent Forward Citations

Loading…